Shin Foong Specialty and Applied Materials Co., Ltd. (6582.TW)
Pingtung, TW
Shin Foong Specialty and Applied Materials Co., Ltd. manufactures and sells synthetic latex products in Taiwan. The company offers synthetic SBR, NBR, acrylic, and bio-latex, that is applied to color layer of thermal paper. Its products are used in various applications, such as adhesive, paper, building and construction, fiber and textile, plastic-free solutions, eco-energy, medical and healthcare, and other specialty solutions. The company was formerly known as Shin Foong Chemical Industry Co., Ltd and changed its name to Shin Foong Specialty and Applied Materials Co., Ltd. in September 2016. Shin Foong Specialty and Applied Materials Co., Ltd. was founded in 1979 and is headquartered in Pingtung, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.82% | -4.55% | -5.74% | -9.52% | -11.37% | -6.17% | -26.03% | -47.04% | -87.20% | -76.06% | -76.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-51.9% Q1'26: -66.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-141.4% Q1'26: -73.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-5.6% Q1'26: -21.8% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-23.9% Q1'26: -44.1% (vs Q1'25)
-
ROIC Chemicals: +3.4%-3.2% Q1'26: -2.6% (vs Q1'25)
-
Share dilution Chemicals: +0.0%0.0% Q1'26: -3.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×-0.47× Q1'26: -0.43× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.97B
est: 3.12B (-4.8%)
|
3.27B
est: 3.12B (+4.8%)
|
5.27B
est: 4.22B (+24.9%)
|
8.16B
est: 3.12B (+161.4%)
|
1.70B
est: 4.22B (-59.6%)
|
1.71B
est: 1.71B (+0.0%)
|
821.39M
est: 3.12B (-73.7%)
|
3.12B
3.12B – 3.12B
+0.0% YoY
|
4.22B
4.22B – 4.22B
+35.1% YoY
|
390.95M
390.95M – 390.95M
-90.7% YoY
|
| EBITDA |
551.58M
est: 876.05M (-37.0%)
|
773.75M
est: 876.05M (-11.7%)
|
2.35B
est: 1.18B (+98.4%)
|
4.51B
est: 876.05M (+414.5%)
|
435.95M
est: 1.18B (-63.2%)
|
235.97M
est: 478.77M (-50.7%)
|
-69.34M
est: 545.09M (-112.7%)
|
545.09M
545.09M – 545.09M
+0.0% YoY
|
736.45M
736.45M – 736.45M
+35.1% YoY
|
68.26M
68.26M – 68.26M
-90.7% YoY
|
| EBIT |
431.98M
est: 644.13M (-32.9%)
|
648.56M
est: 644.13M (+0.7%)
|
2.21B
est: 870.25M (+153.5%)
|
4.36B
est: 644.13M (+576.9%)
|
290.00M
est: 870.25M (-66.7%)
|
103.95M
est: 352.02M (-70.5%)
|
-196.15M
est: 234.13M (-183.8%)
|
234.13M
234.13M – 234.13M
+0.0% YoY
|
316.33M
316.33M – 316.33M
+35.1% YoY
|
29.32M
29.32M – 29.32M
-90.7% YoY
|
| Net Income |
345.10M
est: 506.54M (-31.9%)
|
525.38M
est: 506.54M (+3.7%)
|
1.78B
est: 883.52M (+101.2%)
|
3.48B
est: 506.54M (+586.3%)
|
174.99M
est: 883.52M (-80.2%)
|
104.91M
est: 2.97B (-96.5%)
|
-43.32M
est: 506.45M (-108.6%)
|
506.45M
506.45M – 506.45M
+0.0% YoY
|
883.37M
883.37M – 883.37M
+74.4% YoY
|
2.97B
2.97B – 2.97B
+236.5% YoY
|
| SGA |
217.59M
est: 375.62M (-42.1%)
|
262.94M
est: 375.62M (-30.0%)
|
419.56M
est: 507.48M (-17.3%)
|
500.95M
est: 375.62M (+33.4%)
|
186.94M
est: 507.48M (-63.2%)
|
196.42M
est: 205.28M (-4.3%)
|
99.88M
est: 401.82M (-75.1%)
|
401.82M
401.82M – 401.82M
+0.0% YoY
|
542.88M
542.88M – 542.88M
+35.1% YoY
|
50.32M
50.32M – 50.32M
-90.7% YoY
|
| EPS |
3.46
est: 4.77 (-27.5%)
|
5.01
est: 4.77 (+5.0%)
|
16.85
est: 8.32 (+102.5%)
|
32.65
est: 4.77 (+584.5%)
|
1.65
est: 8.32 (-80.2%)
|
0.99
est: 28.00 (-96.5%)
|
-0.41
est: 4.77 (-108.6%)
|
4.77
4.77 – 4.77
+0.0% YoY
|
8.32
8.32 – 8.32
+74.4% YoY
|
28.00
28.00 – 28.00
+236.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.00% | 1.0K | 0.33% |
| 2 | Avantis Emerging Markets Value ETF AVES | 0.00% | 3.1K | 0.36% |
| 3 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 31.6K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kwong Lai Mok | Assistant Vice President | 2.5K | — |
| Yung Sheng Chang | Assistant Vice President | 2.5K | — |
| Tung Ching Hsu | Assistant Vice President | 2.5K | — |
| Xiuying Qiu | Chief Strategy Officer | — | — |
| Cecil Tseng | Deputy President | — | male |
| Yuting Wang | Accounting Supervisor & Corporate Governance Officer | — | female |
| Cheng Fu Wanf | Financial Director | — | male |
| Li-Mao Wand | Auditing Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6582.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
